Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP598569.RAYU4QU2lNQDBPoSoHJBA4yXkQLYp7eNqgBgsNuRdtkrE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP598569.RAYU4QU2lNQDBPoSoHJBA4yXkQLYp7eNqgBgsNuRdtkrE130_assertion type Assertion NP598569.RAYU4QU2lNQDBPoSoHJBA4yXkQLYp7eNqgBgsNuRdtkrE130_head.
- NP598569.RAYU4QU2lNQDBPoSoHJBA4yXkQLYp7eNqgBgsNuRdtkrE130_assertion description "[The relative frequencies of N-RAS gene mutations in these hematologic disorders was as follows: acute myelogenous leukemia (AML), 15%; acute lymphoblastic leukemia (ALL), 14%; myelodysplastic syndromes, 24%; and myeloid and lymphoid blast crisis of chronic myelogenous leukemia (CML), 3%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP598569.RAYU4QU2lNQDBPoSoHJBA4yXkQLYp7eNqgBgsNuRdtkrE130_provenance.
- NP598569.RAYU4QU2lNQDBPoSoHJBA4yXkQLYp7eNqgBgsNuRdtkrE130_assertion evidence source_evidence_literature NP598569.RAYU4QU2lNQDBPoSoHJBA4yXkQLYp7eNqgBgsNuRdtkrE130_provenance.
- NP598569.RAYU4QU2lNQDBPoSoHJBA4yXkQLYp7eNqgBgsNuRdtkrE130_assertion SIO_000772 2183888 NP598569.RAYU4QU2lNQDBPoSoHJBA4yXkQLYp7eNqgBgsNuRdtkrE130_provenance.
- NP598569.RAYU4QU2lNQDBPoSoHJBA4yXkQLYp7eNqgBgsNuRdtkrE130_assertion wasDerivedFrom befree-20150227 NP598569.RAYU4QU2lNQDBPoSoHJBA4yXkQLYp7eNqgBgsNuRdtkrE130_provenance.
- NP598569.RAYU4QU2lNQDBPoSoHJBA4yXkQLYp7eNqgBgsNuRdtkrE130_assertion wasGeneratedBy ECO_0000203 NP598569.RAYU4QU2lNQDBPoSoHJBA4yXkQLYp7eNqgBgsNuRdtkrE130_provenance.